Despite significant progress, there remains a risk of a mad rush to compliance in late 2023 with pending requirements for ensuring the legitimacy of drug products in the US distribution chain, the Healthcare Distribution Alliance has found.
If laggards miss a 27 November 2023 Drug Supply Chain Security Act deadline, they could face enforcement consequences and their...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?